# Randomized Clinical Study Assessing Haplo vs. URD in AML

> **NCT04067180** · NA · TERMINATED · sponsor: **Karolinska Institutet** · enrollment: 18 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **OTHER:** allogeneic stem cell transplantation with a haplo-identical family donor graft
- **OTHER:** allogeneic stem cell transplantation with a matched unrelated donor graft

## Key facts

- **NCT ID:** NCT04067180
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-12
- **Primary completion:** 2022-08-26
- **Final completion:** 2022-08-26
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Delayed enrollment due to COVID-19 pandemic and other non-alterable world events, including war. The time elapsed when the study was paused has lowered the relevance of the study.
- **Last updated:** 2023-04-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04067180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04067180, "Randomized Clinical Study Assessing Haplo vs. URD in AML". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04067180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*